Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug:73:70-9.
doi: 10.1016/j.micpath.2014.04.005. Epub 2014 Apr 24.

Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection

Affiliations

Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection

Brian T Campfield et al. Microb Pathog. 2014 Aug.

Abstract

Follistatin-like protein 1 (FSTL-1) has recently been described as a critical mediator of CIA and a marker of disease activity. Lyme arthritis, caused by Borrelia burgdorferi, shares similarities with autoimmune arthritis and the experimental murine model collagen-induced arthritis (CIA). Because FSTL-1 is important in CIA and autoimmune arthritides, and Lyme arthritis shares similarities with CIA, we hypothesized that FSTL-1 may be an important mediator of Lyme arthritis. We demonstrate for the first time that FSTL-1 is induced by B. burgdorferi infection and is required for the development of Lyme arthritis in a murine model, utilizing a gene insertion to generate FSTL-1 hypomorphic mice. Using qPCR and qRT-PCR, we found that despite similar early infectious burden, FSTL-1 hypomorphic mice have improved spirochetal clearance in the face of attenuated arthritis and inflammatory cytokine production. Further, FSTL-1 mediates pathogen-specific antibody production and antigen recognition when assessed by ELISA and one- and two-dimensional immunoblotting. This study is the first to describe a role for FSTL-1 in the development of Lyme arthritis and anti-Borrelia response, and the first to demonstrate a role for FSTL-1 in response to infection, highlighting the potential for FSTL-1 as a target in the treatment of B. burgdorferi infection.

Keywords: Arthritis; Borrelia burgdorferi; FSTL-1; Lyme disease; Mouse model; humoral immunity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
FSTL-1 hypomorphic mice have decreased fstl-1 gene transcription and FSTL-1 serum protein. (A). A 2565 bp insert containing loxP sequence was inserted within the fstl-1 exon 1 along with flP, a neomycin cassette, a second flP and second loxP site, and was (B) detectable by PCR as FSTL-1 hypomorphic mice yielded a 238 bp gene product (hypo) while wild-type (WT) mice yielded a 199 bp band; in heterozygotes (het) both gene products were detectable. (C) This insertion resulted in FSTL-1 hypomorphic mice with a 60% reduction in serum FSTL-1 (D). Hypomorphic mice showed a reduction in joint fstl-1 transcription versus wild-type mice at day 14 and 42 post infection. Data are representative of at least two individual experiments with n = 10 mice/treatment group. **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fig. 2
Fig. 2
FSTL-1 mediates the development of Lyme arthritis. (A) DBA/1WT (squares) and FSTL-1 hypomorph mice (circles) were infected with 106 Borrelia burgdorferi (solid) or media alone (open). (B) H&E stained tibiotarsal joints of day 42 Borrelia burgdorferi-infected WT and FSTL-1 hypomorph mice were scored for inflammation. Shown are representative 4× (C, E) and 10× (D, F) images of day 42 Bb infected WT (C, D) and FSTL-1 hypomorphic (E, F) mice. Arrow denotes synovial proliferation. b, Bone; s, synovium. *p = 0.03; **p < 0.01. Data are representative of at least two individual experiments with n = 10 mice/treatment group.
Fig. 3
Fig. 3
FSTL-1 hypomorphic mice have attenuated Borrelia burgdorferi burden in target tissues. qPCR for ospC of extracted DNA from (A) hearts and (B) joints of WT and FSTL-1 hypomorph mice 14 and 42 days post infection with 106 Borrelia burgdorferi. Error bars represent SEM. Data are representative of at least two individual experiments with n = 10 mice/treatment group. **p < 0.01; ***p < 0.001.
Fig. 4
Fig. 4
FSTL-1 influences inflammatory cytokine production in vivo. WT and FSTL-1 hypomorph mice were infected with 106 Borrelia burgdorferi and qRT-PCR performed on (A) hearts and (B) joints for IL-6, IL-1β and TNFα at indicated time points. n = 10 mice/treatment group. Each dot represents an individual animal tissue. Bars represent mean for each treatment group. *p < 0.05.
Fig. 5
Fig. 5
FSTL-1 influences immunoglobulin production in response to B. burgdorferi infection. ELISA plates coated with B. burgdorferi membrane-associated proteins were probed with individual B. burgdorferi-infected DBA/1 WT and FSTL-1 hypomorphic mouse serum and detected using class- and isotype-specific secondary antibodies at (A) 14 days post infection and (B) 42 days post infection. Data are representative of at least two individual experiments with n = 10 mice/treatment group. Each ELISA was performed ≥3 times. Mean values are depicted with standard error.
Fig. 6
Fig. 6
FSTL-1 is critical to Borrelia burgdorferi antigen recognition. (A) B. burgdorferi membrane-associated proteins (MAP) (15 μg) separated by one-dimensional SDS–PAGE were probed with pooled serum (n = 10 per group) from WT and FSTL-1 hypomorphic mice at 42 days post B. burgdorferi infection with detection of polyclonal IgG/IgM reactivity. Fifty micrograms of B. burgdorferi MAP were separated using IPG followed by SDS–PAGE and transferred to nitrocellulose membrane. Pooled sera from both (B) WT and (C) FSTL-1 hypomorphic mice (n = 10) were used to probe blots followed by detection of polyclonal IgG/IgM reactivity. Resulting two-dimensional serologic maps were correlated with previously identified proteins. Bold and underlined proteins indicate MAPs recognized by WT but not FSTL-1 hypomorphic serum. Data are representative of two individual experiments with n = 10 mice/treatment group.

Similar articles

Cited by

References

    1. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease–United States, 1992-2006. MMWR Surveill Summ. 2008;57:1–9. - PubMed
    1. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 1977;20:7–17. - PubMed
    1. Harjacek M, Diaz-Cano S, Alman BA, Coburn J, Ruthazer R, Wolfe H, et al. Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J Rheumatol. 2000;27:497–503. - PubMed
    1. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429–42. - PubMed
    1. Miller JC, Ma Y, Crandall H, Wang X, Weis JJ. Gene expression profiling provides insights into the pathways involved in inflammatory arthritis development: murine model of Lyme disease. Exp Mol Pathol. 2008;85:20–7. - PMC - PubMed

Publication types